Allergan reports 48% rise in quarterly revenues
Allergan, whose $160 billion merger with Pfizer fell apart last month, today reported a better than expected quarterly profit today, led by strong sales of wrinkle treatment Botox and eye drug Restasis.
Business
• 10 May 16